These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 25338997)
1. TGF-β1 protein expression in non-small cell lung cancers is correlated with prognosis. Huang AL; Liu SG; Qi WJ; Zhao YF; Li YM; Lei B; Sheng WJ; Shen H Asian Pac J Cancer Prev; 2014; 15(19):8143-7. PubMed ID: 25338997 [TBL] [Abstract][Full Text] [Related]
2. GOLPH3 high expression predicts poor prognosis in patients with resected non-small cell lung cancer: an immunohistochemical analysis. Zhang Y; Ma M; Han B Tumour Biol; 2014 Nov; 35(11):10833-9. PubMed ID: 25081375 [TBL] [Abstract][Full Text] [Related]
3. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer. Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393 [TBL] [Abstract][Full Text] [Related]
4. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker. Wei K; Ye Z; Li Z; Dang Y; Chen X; Huang N; Bao C; Gan T; Yang L; Chen G World J Surg Oncol; 2016 Feb; 14(1):34. PubMed ID: 26860827 [TBL] [Abstract][Full Text] [Related]
5. HSP90B1 overexpression predicts poor prognosis in NSCLC patients. Xu Y; Chen Z; Zhang G; Xi Y; Sun R; Wang X; Wang W; Chai F; Li X Tumour Biol; 2016 Oct; 37(10):14321-14328. PubMed ID: 27599983 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of TAZ expression in resected non-small cell lung cancer. Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233 [TBL] [Abstract][Full Text] [Related]
8. High TBX2 expression predicts poor prognosis in non-small cell lung cancer. Zhang Z; Guo Y Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of muscarinic receptor 3 promotes metastasis and predicts poor prognosis in non-small-cell lung cancer. Lin G; Sun L; Wang R; Guo Y; Xie C J Thorac Oncol; 2014 Feb; 9(2):170-8. PubMed ID: 24419413 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of SH2B1 adaptor protein expression in non-small cell lung cancer. Zhang H; Duan CJ; Chen W; Wang SQ; Zhang SK; Dong S; Cheng YD; Zhang CF Asian Pac J Cancer Prev; 2012; 13(5):2355-62. PubMed ID: 22901222 [TBL] [Abstract][Full Text] [Related]
11. RBX1 expression is an unfavorable prognostic factor in patients with non-small cell lung cancer. Xing R; Chen KB; Xuan Y; Feng C; Xue M; Zeng YC Surg Oncol; 2016 Sep; 25(3):147-51. PubMed ID: 27566015 [TBL] [Abstract][Full Text] [Related]
12. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance. Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853 [TBL] [Abstract][Full Text] [Related]
13. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer. Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750 [TBL] [Abstract][Full Text] [Related]
14. Expression of tumor necrosis factor receptor-associated factor 6 in lung cancer tissues. Zhang XL; Dang YW; Li P; Rong MH; Hou XX; Luo DZ; Chen G Asian Pac J Cancer Prev; 2014; 15(24):10591-6. PubMed ID: 25605144 [TBL] [Abstract][Full Text] [Related]
15. [Association of HAb18G with clinicopathologic features and prognosis in non-small cell carcinoma of lung]. Xu XY; Zhi C; Li YM; Qi WJ; Mei JJ; Yan ZM; Shen H Zhonghua Bing Li Xue Za Zhi; 2012 Mar; 41(3):151-5. PubMed ID: 22800476 [TBL] [Abstract][Full Text] [Related]
16. PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups. Schmidt LH; Kümmel A; Görlich D; Mohr M; Bröckling S; Mikesch JH; Grünewald I; Marra A; Schultheis AM; Wardelmann E; Müller-Tidow C; Spieker T; Schliemann C; Berdel WE; Wiewrodt R; Hartmann W PLoS One; 2015; 10(8):e0136023. PubMed ID: 26313362 [TBL] [Abstract][Full Text] [Related]
17. ADAM17 is overexpressed in non-small cell lung cancer and its expression correlates with poor patient survival. Ni SS; Zhang J; Zhao WL; Dong XC; Wang JL Tumour Biol; 2013 Jun; 34(3):1813-8. PubMed ID: 23475633 [TBL] [Abstract][Full Text] [Related]
18. Ly6/uPAR-related protein C4.4A as a marker of solid growth pattern and poor prognosis in lung adenocarcinoma. Jacobsen B; Muley T; Meister M; Dienemann H; Christensen IJ; Santoni-Rugiu E; Lærum OD; Ploug M J Thorac Oncol; 2013 Feb; 8(2):152-60. PubMed ID: 23287851 [TBL] [Abstract][Full Text] [Related]
19. Alterations of MET Gene Copy Number and Protein Expression in Primary Non-Small-Cell Lung Cancer and Corresponding Nodal Metastases. Tran TN; Selinger CI; Kohonen-Corish MR; McCaughan B; Kennedy C; O'Toole SA; Cooper WA Clin Lung Cancer; 2016 Jan; 17(1):30-8.e1. PubMed ID: 26395411 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of annexin II expression in non-small cell lung cancer. Luo CH; Liu QQ; Zhang PF; Li MY; Chen ZC; Liu YF Clin Transl Oncol; 2013 Nov; 15(11):938-46. PubMed ID: 23529818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]